
OCRA’s Advocate’s Corner: June 2025
Written by Chad Ramsey, Vice President, Policy, Ovarian Cancer Research Alliance FY26 Budget Update: Critical Cancer Programs at Risk Congress is deep into its work on the fiscal year 2026 … Continued
Written by Chad Ramsey, Vice President, Policy, Ovarian Cancer Research Alliance FY26 Budget Update: Critical Cancer Programs at Risk Congress is deep into its work on the fiscal year 2026 … Continued
FY26 Budget Watch, Advocacy Results, and State-Level Progress As Congress ramps up work on the FY26 federal budget, advocates are focused on maintaining vital cancer programs and advancing state policies … Continued
A new article from Patient Power highlights findings from a paper authored by Ovarian Cancer Research Alliance (OCRA) and Komodo Health, that reveals significant gaps in genetic testing for ovarian … Continued
Spring is here—and so is appropriations season in Washington, DC. This month has brought key developments in both the FY26 federal budget process and state-level policy action that could impact gynecologic cancer … Continued
New administrations inevitably bring changes, both big and small. The top priority of OCRA’s Policy & Advocacy team remains the same—ensuring the voices of the ovarian and gynecologic cancer community … Continued
In a new article from TheaterMania, ovarian cancer survivor and OCRA Advocate Leader Kristen Jantonio shares how her passion for theater has been a source of strength and inspiration since being … Continued
OCRA Joins Forces With Rivkin Center for Ovarian Cancer Research Ovarian Cancer Research Alliance (OCRA) has announced that the Rivkin Center for Ovarian Cancer Research will join with OCRA effective … Continued
Happy New Year from OCRA’s Policy and Advocacy Team! As we step into a new year, we want to take a moment to thank you for your unwavering support and … Continued
As we close out 2024, we at OCRA are reflecting on a year of powerful advocacy and immense gratitude. Your passion and commitment to raising awareness, driving policy change, and … Continued
“To improve patient outcomes – and quality of life – we must minimize roadblocks for access to cancer screenings that could change the course of a diagnosis. The time is … Continued
OCRA recently joined the Inter-Organization Cancer Genetics Clinical Evidence Coalition (INTERACT), which is working to ensure genetic testing access for all who may carry inherited mutations that increase the risk … Continued
International Forum on Ovarian Cancer Aims to Accelerate Progress Ovarian Cancer Research Alliance (OCRA) President and CEO Audra Moran, along with members of the OCRA team, joined leading scientists and … Continued
Get email updates about research news, action alerts, and ways to join the fight.